[Chronic Mesenteric Ischemia]

Christian Heiss1

  • 1University of Surrey, Faculty of Health and Medical Science, Guildford, United Kingdom und Surrey and Sussex NHS Healthcare Trust, Redhill, United Kingdom.

Insights

Chronic mesenteric ischemia (CMI) involves blockages in abdominal arteries, often due to atherosclerosis. Revascularization, typically angioplasty with stenting, is the preferred treatment for symptomatic CMI.

Area of Science:

  • Vascular Surgery
  • Gastroenterology
  • Interventional Radiology

Background:

  • Chronic mesenteric ischemia (CMI) results from narrowed or blocked celiac, superior, or inferior mesenteric arteries.
  • Atherosclerosis is the primary cause, but fibromuscular dysplasia and vasculitis are less common, especially in younger individuals.
  • Risk factors include smoking, hypertension, dyslipidemia, advanced age, and female sex.

Purpose of the Study:

  • To review the definition, causes, risk factors, and clinical presentation of CMI.
  • To discuss diagnostic modalities and therapeutic options for CMI.
  • To highlight the importance of revascularization and risk factor modification in managing CMI.

Main Methods:

  • Literature review of CMI definition, etiology, risk factors, clinical signs, diagnostic tools, and treatment strategies.
  • Analysis of diagnostic modalities, emphasizing duplex ultrasound and functional testing.
  • Evaluation of revascularization techniques, including angioplasty with stenting and surgical options.

Main Results:

  • Symptomatic CMI accounts for <5% of intestinal ischemic events, while asymptomatic CMI prevalence may reach 15%.
  • The celiac artery is most frequently affected.
  • Angioplasty with stenting offers high technical and clinical success rates with low mortality, making it the therapy of choice.

Conclusions:

  • CMI diagnosis requires a high index of suspicion based on clinical symptoms and confirmed by imaging.
  • Revascularization is the primary treatment for symptomatic CMI, with endovascular approaches preferred.
  • Lifestyle modifications and optimal medical therapy are crucial for managing underlying atherosclerosis and preventing recurrence.

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
12.0K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
744
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
802
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
371
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
733
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K